“More and more in the U.S., people are making choices between a bag of groceries and a medicine, a copay. The long-term sustainability of the industry and our ability to deliver breakthrough medicines requires us to demonstrate value.”
President, AstraZeneca U.S.
Many of our In Focus readers have management responsibilities that go beyond their companies’ healthcare plans and extend into the qualified plans arena, most frequently with their companies’ 401(k) plans. Typically, the concerns of healthcare and 401(k) plan management don’t intersect. But in March, in a Boston hotel room, such an intersection did take place. It’s an intersection that may make a difference to how benefits managers and their prescription drug plan members will be urged to perceive the value proposition of prescription drugs. (more…)